The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
17th Nov 20201:30 pmRNSResult of AGM
17th Nov 20207:00 amRNSAGM Statement
19th Oct 20207:00 amRNSNotice of AGM & Q1 Trading Update
15th Oct 20207:00 amRNSBlock listing Interim Review
2nd Oct 20203:55 pmRNSGrant of Long Term Incentive Plan Awards
21st Sep 20207:00 amRNSFinal Results
18th Aug 20207:00 amRNSPurchase of Shares and Exercise of Share Options
12th Aug 20207:00 amRNSUpdate on Proposed Placing
11th Aug 20205:00 pmRNSProposed Accelerated Bookbuild
8th Jul 20207:00 amRNSTrading Update
18th Jun 20202:37 pmRNSHolding(s) in Company
21st Apr 20205:04 pmRNSGrant of Share Options
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
15th Apr 20205:15 pmRNSBlock listing Interim Review
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20204:31 pmRNSVesting of Long Term Incentive Plan Award
20th Mar 20202:02 pmRNSDividend Currency Election
20th Mar 20209:00 amRNSBlocklisting Application
3rd Mar 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSBoard Appointments
23rd Jan 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Dec 20193:15 pmRNSDirector/PDMR Shareholding and Total Voting Rights
20th Dec 201912:10 pmRNSHolding(s) in Company
29th Nov 201912:29 pmRNSDividend Currency Election
25th Nov 20195:23 pmRNSHolding(s) in Company
22nd Nov 201911:01 amRNSTotal Voting Rights
18th Nov 20197:00 amRNSShare Purchase by Chairman Designate
13th Nov 20194:10 pmRNSResult of AGM
12th Nov 20197:00 amRNSAGM Statement
16th Oct 201910:46 amRNSBlock listing Interim Review
11th Oct 20194:17 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20194:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
18th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 201912:03 pmRNSHolding(s) in Company
4th Sep 20196:14 pmRNSGrant of Long Term Incentive Plan Awards
3rd Sep 20197:00 amRNSFinal Results
2nd Sep 201911:23 amRNSBlocklisting Application
1st Jul 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20199:05 amRNSSecond Price Monitoring Extn
28th Jun 20199:00 amRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTrading Update and Notice of Results
15th Apr 20197:00 amRNSBlock listing Interim Review
15th Mar 20192:50 pmRNSDividend Currency Election
5th Mar 20197:00 amRNSHalf-year Report
21st Dec 20187:00 amRNSTrading Update and Notice of Results
15th Nov 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.